Bioavailability enhancement techniques of herbal medicine: A case example of curcumin

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.1, 2013, Pages 493-500

  Jantarat, Chutima ^a  

^a WALAILAK UNIVERSITY   (Thailand)

Author keywords

Bioavailability; Curcumin; Curcumin derivatives; Herbal medicine; Natural enhancer; Pharmaceutical technology; Transdermal delivery

Indexed keywords

1, 3 DIKETONE; CHITOSAN; CURCUMIN; CYCLODEXTRIN; EPIGALLOCATECHIN GALLATE; HUMAN SERUM ALBUMIN; HYALURONIC ACID; LIPOSOME; MACROGOL; NANOPARTICLE; PHOSPHOLIPID; PIPERINE; PYRAZOLE; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; BLACK PEPPER; BREAST CANCER; CHEMICAL STRUCTURE; DRUG CONJUGATION; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; ELECTROPORATION; ENHANCER REGION; HERBAL MEDICINE; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; IONTOPHORESIS; LIVER METABOLISM; MICROEMULSION; NANOTECHNOLOGY; NONHUMAN; PHARMACODYNAMICS; PSORIASIS; SCLERODERMA; SKIN CANCER; STRATUM CORNEUM; TRANSDERMAL PATCH;

EID: 84875460490     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 2012; 69: 679-689.
2. Suresh D, Srinivasan K. Studies on the in vitro absorption of spice principles-curcumin, capsaicin and piperine in rat intestines. Food Chem Toxicol 2007; 45: 1437-1442.
3. Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997; 166: 169-175.
4. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN, Aggarwal BB. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008; 76: 1590-1611.
5. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809.
6. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic autoimmune and neoplastic diseases. In J Biochem Cell Biol 2009; 41: 40-59.
7. Goel A, Jhurani S, Aggarwal BB. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 2008; 52: 1010-1030.
8. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807-818.
9. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-398.
10. Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol 2000; 129: 231-234.
11. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Res 2001; 21: 2895-2900.
12. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10: 6847-6854.
13. Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH. Recent advances in the investigation of curcuminoids. Chinese Medicine 2008; 3: 11.
14. Tomren MA, Masson M, Loftsson T, Hjorth Tonnesen H. Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: Stability, activity and complexation with cyclodextrin. Int J Pharm 2007; 338: 27-34.
15. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011; 77: 275-282.
16. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997; 15: 1867-1876.
17. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999; 27: 486-494.
18. Huadong T, Murphy CJ, Zhang B, Shen Y, Van Kirk EA, Murdoch WJ, Radosz M. Curcumin polymers as anticancer conjugates. Biomaterials 2010; 31: 7139-7149.
19. Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X, Yang S. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg Medicinal Chem 2009; 17: 2623-31.
20. Airoldi C, Zona C, Sironi E, Colombo L, Messa M, Aurilia D, Gregori M, Masserini M, Salmona M, Nicotra F, Ferla BL. Curcumin derivatives as new ligands of Aβ peptides. J Biotechnol 2011; 156: 317-324.
21. Pandey MK, Balwani S, Sharma PK, Parmar VS, Ghosh B, Watterson AC. Design, synthesis and anti-inflammatory evaluation of PEGylated 4-methyl-and 4, 8-dimethylcoumarins. Eur J Pharm Sci 2010; 39: 134-140.
22. Pandey MK, Tyagi R, Tomar S, Kumar J, Parmar VS, Watterson AC. Design and synthesis of novel pegylated 4-methylcoumarins. J Macromol Sci, Pure Appl Chem 2007; 44: 1293-1298.
23. Pandey MK, Kumar S, Thimmulappa RK, Parmar VS, Biswal S, Watterson AC. Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. Eur J Pharm Sci 2011; 43: 16-24.
24. Parvathy KS, Negi PS, Srinivas P. Curcumin-amino acid conjugates: synthesis, antioxidant and antimutagenic attributes. Food Chem 2010; 120: 523-530.
25. Manju S, Sreenivasan K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interf Sci 2011; 359: 318-325.
26. Paramera EI, Konteles SJ, Karathanos VT. Stability and release properties of curcumin encapsulated in Saccharomyces cerevisiae, β-cyclodextrin and modified starch. Food Chem 2011; 125: 913-922.
27. Yallapu MM, Jaggi M, Chauhan SC. B-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B 2010; 79: 113-125.
28. Yadav VR, Suresh S, Devi K, Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS Pharm Sci Tech 2009; 10: 752-762.
29. Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244: 127-135.
30. Tapal A, Tiku PK. Complexation of curcumin with soy protein isolate and its implications on solubility and stability of curcumin. Food Chem 2012; 130: 960-965.
31. Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012; 17: 71-80.
32. Das M, Mohanty C and Sahoo SK. Ligand-based targeted therapy for cancer tissue. Expert Opin Drug Deliv 2009; 6: 285-304.
33. Sahu A, Kasoju N, Bora U. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 2008; 9: 2905-2912.
34. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002; 82: 105-114.
35. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007; 25, 1165-1170.
36. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21: 387-422.
37. Yallapu MM, Gupta BK, Jagg M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 2010; 351: 19-29.
38. Liu J, Xu L, Liu C, Zhang D, wang S, Deng Z, Lou W, Xu H, Bai Q, Ma J. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohyd Polym 2012; 90: 16-22.
39. Tsai YM, Jan WC, Chien CF, Lee WC, Lin LC, Tsai TH. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem 2011; 127: 918-925.
40. Shaikh J, Ankola DD, Beniwal V, Singh D, Ravi Kumar MNV. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009; 37: 223-230.
41. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011; 403: 285-291.
42. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182: 21-32.
43. Akhtar F, Rizvi MMA, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 2012; 30: 310-320.
44. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP, Burke TG, Ranjan D. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 2009; 366: 133-139.
45. Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an oral carrier system in rat: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 2009; 57: 9141-9146.
46. Iwunze MO. Binding and distribution characteristics of curcumin solubilized in CTAB micelle. J Mol Liq 2004; 111: 161-165.
47. Esmaili M, Ghaffari SM, Moosavi-Movahedi Z, Atri MS, Sharifizadeh A, Farhadi M, Yousefi R, Chobert JM, Haertle T, Moosavi-Movahedi AA. Beta casein-micelle as an nano vehicle for solubility enhancement of curcumin; food industry application. LWT-Food Sci Tech 2011; 44: 2166-2172.
48. Song L, Shen Y, Hou J, Lei L, Guo S, Qian C. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloid Surface A: Physicochem Eng Aspects 2011; 390: 25-32.
49. Song Z, Feng R, Sun M, Guo C, Gao Y, Li L, Zhai G. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interf Sci 2011; 354: 116-123.
50. Liu A, Lou H, Zhao L, Fan P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 2006; 40: 720-727.
51. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007; 330: 155-163.
52. Shishu, Maheshwari M. Comparative bioavailability of curcumin, turmeric and Biocurcumax™ in traditional vehicles using non-everted rat intestinal sac model. J Func Foods 2010; 2: 60-65.
53. Kang MJ, Cho JY, Shim BH, Kim DK, Lee J. Bioavailability enhancing activities of natural compounds from medicinal plant. J Med Plants Res 2009; 3: 1204-1211.
54. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64: 353-356.
55. Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006; 4: 1035-1038.
56. Balasubramanian S, Eckert RL. Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function. J Biol Chem 2004; 279: 24007-24014.
57. IM K, Ravi A, Kumar D, Kuttan R, Maliakel B. An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. J Func Foods 2012; 4: 348-357.
58. Dowthamarajan K, Jawahar N, Wake P, Jain K, Sood S. Development of buccal tablets for curcumin using Anacardium occidentale gum. Carbohyd Polym 2012; 88: 1177-1183.
59. Das R. Effective mucoadhesive buccal patches: wound healing activity of curcumin & centella asiatica extract compared to rhEGF. Int J Pharm Pharm Sci 2011; 3: 97-100.
60. Thangapazham RL, Sharma A, Maheshwari RK. Beneficial role of curcumin in skin diseases. Adv Exp Med Biol 2007; 595: 343-357.
61. Fang JY, Hung CF, Chiu HC, Wang JJ, Chan TF. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin. J Pharm Pharmacol 2003; 55: 593-601.
62. Liu CH, Chang FY, Hung DK. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B 2011; 82: 63-70.
63. Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006; 123-126: 369-385.
64. Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RHH, Sterry W, Lademann J. Comarison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm 2007; 67: 699-706.
65. Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012; 4: 239-250.
66. Li X, Nan K, Li L, Zhang Z, Chen H. In vivo evaluation of curcumin nanoformulation loaded methoxy poly(ethylene glycol)-graft-chitosan composite film for wound healing application. Carbohyd Polym 2012; 88: 84-90.
67. Sharma S, Pawar S, Jain UK. Development and evaluation of topical gel of curcumin from different combination of polymers formulation & evaluation of herbal gel. Int J Pharm Pharm Sci 2012; 4: 452-456.
68. Chang CC, Yang WT, Ko SY, Chiang Y. Liposomal curcuminoids for transdermal delivery: iontophoresis potential for breast cancer chemotherapeutics. Dig J Nanomater Bios 2012; 7: 59-71.